CYTTA CORP. | |||||||||||||||||||||||||||||||||||||||||||||||||
Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
Balance Sheet Date | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | |||||||||||||||||||||||||||||||
Fiscal Period | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2014 | Q1-FY2014 | Q4-FY2013 | |||||||||||||||||||||||||||||||
Price to Sales | |||||||||||||||||||||||||||||||||||||||||||||||||
Forward Price to Sales MRQ | |||||||||||||||||||||||||||||||||||||||||||||||||
Price to Book | |||||||||||||||||||||||||||||||||||||||||||||||||
Price to Earnings | |||||||||||||||||||||||||||||||||||||||||||||||||
Forward Price to Earnings MRQ | |||||||||||||||||||||||||||||||||||||||||||||||||
Debt to Asset Ratio | .18x | 1.62x | 1.11x | .96x | 2.22x | 1.71x | 1.11x | 2.70x | 1.66x | 1.81x | .49x | .26x | .10x | .07x | .32x | .37x | 8.09x | 5.31x | 1.10x | ||||||||||||||||||||||||||||||
Current Ratio | 5.54x | .59x | .82x | .92x | .32x | .39x | .65x | .33x | .48x | 1.75x | 3.61x | 2.71x |